Berlex continues legal challenge to FDA over MS drug.
Glaser
V
V
D017277:Drug Approval; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009965:Orphan Drug Production / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration
D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a